Comparison of High-Flow Nasal Cannula and Conventional Oxygen Therapy for High-Risk Patients During Bronchoscopy Examination: A Multi-Center Randomized Controlled Trial
Abstract
RATIONALE
Despite the increasing use of high-flow nasal cannula (HFNC) oxygen therapy during endoscopy examination, its impact on high-risk patients remains uncertain.
OBJECTIVES
we aimed to compare HFNC and conventional oxygen therapy (COT) during nasal bronchoscopy in patients at high-risk for desaturation (morbid obesity, narrow trachea, or baseline hypoxemia and/or hypercapnia).
MEASUREMENTS
In this multicenter randomized controlled trial (RCT), patients scheduled for bronchoscopy and presenting with any high-risk factors were randomly assigned to receive HFNC or COT after providing written consent. Vital signs, pulse oximetry (SpO2), and transcutaneous carbon dioxide (PtCO2) were continuously monitored. The occurrence of desaturation (SpO2≤90% lasted >10s), frequency of examination interruption and treatment escalation were compared between groups.
RESULTS
Of 148 initially enrolled patients, six withdrew, leaving 72 and 70 in the HFNC and COT groups, respectively. Most of the patients had airway stenosis. HFNC significantly reduced desaturation occurrence during bronchoscopy (34.7 vs. 61.4%, p=0.016), with fewer instances of examination interruption (26.4 vs. 58.6%, p<0.001) and less frequent treatment escalation (30.6 vs. 57.1%, p=0.001). During the examination, the lowest SpO2 was higher with HFNC (94[IQR, 87-98] vs 87.5[79-93]%, p=0.001), while the highest PtCO2 was lower (64.6[56.8-70.1] vs 68.3[62.3-77.0] mmHg, p=0.04). No significant differences were observed…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 148 participants or records.
Read the paper
Related studies
- Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials
- Tocilizumab in patients with severe COVID-19: a retrospective cohort study
- A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study
- Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study
- Are noise and air pollution related to the incidence of dementia? A cohort study in London, England
- Long COVID symptoms and duration in SARS-CoV-2 positive children — a nationwide cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.